Transcribed
Episodes
Lindsay Edwards on building AI that actually works in biology
08 May 2026
Contributed by Lukas
Lindsay Edwards went from producing UK top ten singles with Sting and Whitney Houston to pioneering the first data science group at GSK — and he's c...
Jacob Berlin on why chemistry is the last frontier for AI drug discovery
13 Apr 2026
Contributed by Lukas
Jacob Berlin spent years perfecting a microarray chip the size of a fingernail before he thought about starting a company. Now, as cofounder and CEO o...
Kate Haviland on strategic pivots and turning a phase three failure into a blockbuster
07 Apr 2026
Contributed by Lukas
Kate Haviland knows how to push through clinical setbacks and turn breakthrough science into life-changing therapies. As former CEO of Blueprint Medic...
Janice Chen on the CRISPR endgame and why the biggest barrier isn’t scientific
31 Mar 2026
Contributed by Lukas
Janice Chen cofounded Mammoth Biosciences straight out of Jennifer Doudna's lab — and she's been rewriting the CRISPR playbook ever since. In this e...
Nicole Paulk on radical ideas and the quest for a universal gene therapy
19 Feb 2026
Contributed by Lukas
Nicole Paulk talks about turning moonshots into companies, why unpopular ideas are the right ones to pursue, and how biotech has to move faster and ch...
Gleb Kuznetsov on breaking the in vivo bottleneck and building a true platform company
09 Feb 2026
Contributed by Lukas
Gleb Kuznetsov talks about about ditching Google for grad school, what it takes to build a true platform company, and where AI-driven drug discovery i...
Andrew Bellinger on contrarian bets — and pioneering gene editing at Verve
22 Oct 2025
Contributed by Lukas
Andrew Bellinger discusses what it takes to build new drug modalities from scratch, the bold bets and tough calls that shaped Verve’s journey, and l...
Jake Becraft on going all in on mRNA and proving skeptics wrong
10 Sep 2025
Contributed by Lukas
Jake Becraft reflects on making bold bets in mRNA, the journey from lab bench to biotech founder, and the state of science today.(00:00) Introduction ...
Karen Akinsanya on the future of computational drug discovery
01 Aug 2025
Contributed by Lukas
Karen Akinsanya unpacks the rise of computational drug discovery, what it takes to prove impact of new technologies, and the importance of setting rea...
Sara Kenkare-Mitra on saving drug programs and following your curiosity
01 Aug 2025
Contributed by Lukas
Sara Kenkare-Mitra talks about resilience, risk, and the kind of leadership it takes to save failing drug programs — and make medicines that matter....
Patrick Hsu on betting big: CRISPR, AI, and building science in the open
01 Aug 2025
Contributed by Lukas
Patrick Hsu reflects on the early days of CRISPR, the power of mentorship, and how AI and open science will reshape the future of research.(00:00) Int...